• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶生成增加的标志物。

Markers of increased thrombin generation.

作者信息

Prisco D

机构信息

Clinica Medica I, Università degli Studi di Firenze.

出版信息

Ric Clin Lab. 1990 Oct-Dec;20(4):217-25. doi: 10.1007/BF02900706.

DOI:10.1007/BF02900706
PMID:2075375
Abstract

Blood clotting activation causes an increased thrombin generation. The direct measurement of plasma thrombin is not feasible due to the absence of reliable methods. Thus, only indirect approaches are possible. Different markers of thrombin generation have been proposed in the past years. Some methods are nowadays of historical interest. Among various methods reported the 'gold standard' is fibrinopeptide A assay, while thrombin-antithrombin complexes assay needs further validation to be employed as a reliable index of increased thrombin generation, and more recent methods (such as those for F1+2 fragment and for protein C activation peptide) are not available for routine use.

摘要

血液凝固激活会导致凝血酶生成增加。由于缺乏可靠的方法,直接测量血浆凝血酶并不可行。因此,只能采用间接方法。在过去几年中,已经提出了不同的凝血酶生成标志物。如今,有些方法只具有历史意义。在报道的各种方法中,“金标准”是纤维蛋白肽A测定法,而凝血酶-抗凝血酶复合物测定法需要进一步验证才能作为凝血酶生成增加的可靠指标,并且更新的方法(如F1+2片段和蛋白C激活肽的测定方法)尚不能用于常规检测。

相似文献

1
Markers of increased thrombin generation.凝血酶生成增加的标志物。
Ric Clin Lab. 1990 Oct-Dec;20(4):217-25. doi: 10.1007/BF02900706.
2
Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.在体外循环手术期间用凝血酶原片段1.2检测法监测凝血酶生成
Thromb Res. 1996 Oct 1;84(1):45-54. doi: 10.1016/0049-3848(96)00160-0.
3
Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆中凝血酶原片段1+2与凝血酶-抗凝血酶III复合物的比较。
Blood Coagul Fibrinolysis. 1992 Dec;3(6):813-8. doi: 10.1097/00001721-199212000-00037.
4
Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.体外自凝全血中的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及纤维蛋白肽A。添加肝素及抗凝血酶III缺乏的影响。
Thromb Haemost. 1994 Jan;71(1):49-53.
5
Increased thrombin generation in normal pregnancy.正常妊娠中凝血酶生成增加。
Acta Eur Fertil. 1988 Sep-Oct;19(5):263-7.
6
Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.通过止血分子标志物对心脏手术期间凝血酶原激活的特征分析。
Anesthesiology. 1994 Mar;80(3):520-6. doi: 10.1097/00000542-199403000-00007.
7
Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.孕期预防性给予抗凝血酶III可通过形成凝血酶-抗凝血酶III复合物,立即降低先天性抗凝血酶III缺乏症患者的凝血酶活性亢进。
Thromb Res. 1992 Jun 1;66(5):509-15. doi: 10.1016/0049-3848(92)90305-t.
8
Hemostasis activation markers in acute renal failure.
Ren Fail. 1998 Jan;20(1):147-55. doi: 10.3109/08860229809045097.
9
Activation of the plasma coagulation system induced by some biomaterials.某些生物材料引起的血浆凝血系统激活。
J Biomed Mater Res. 1996 May;31(1):145-8. doi: 10.1002/(SICI)1097-4636(199605)31:1<145::AID-JBM16>3.0.CO;2-M.
10
[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].[凝血酶、抗凝血酶、凝血酶 - 抗凝血酶复合物(TAT)]
Nihon Rinsho. 2004 Dec;62 Suppl 12:626-8.

引用本文的文献

1
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy.小腿创伤后体内和体外凝血酶生成增强,但膝关节镜检查后未出现这种情况。
Thromb J. 2023 Apr 28;21(1):49. doi: 10.1186/s12959-023-00493-4.
2
Hemodialysis for removal of dabigatran in a patient with gastric hemorrhage.采用血液透析清除一名胃出血患者体内的达比加群。
Acute Med Surg. 2015 Jun 30;3(2):132-134. doi: 10.1002/ams2.123. eCollection 2016 Apr.
3
A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.
一组糖蛋白作为 B 细胞急性淋巴细胞白血病早期诊断和治疗评估的候选生物标志物。
Biomark Res. 2016 Jan 27;4:1. doi: 10.1186/s40364-016-0055-6. eCollection 2016.